Indirect coating of RGD peptides using a poly- L -lysine spacer enhances jaw periosteal cell adhesion, proliferation, and differentiation into osteogenic tissue

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 8, 2012, Pages 2034-2044

  Ardjomandi, N ^a   Klein, C ^a   Kohler, K ^a   Maurer, A ^b   Kalbacher, H ^b   Niederlander J ^a   Reinert, S ^a   Alexander, D ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

integrin mediated adhesion; jaw periosteal cells; mineralization; polylactic acid scaffolds; proliferation; RGD peptides

Indexed keywords

MINERALIZATION; PERIOSTEAL CELLS; POLY LACTIC ACID; PROLIFERATION; RGD PEPTIDE;

ADHESION; AMINO ACIDS; BIOMATERIALS; CELL ADHESION; CELL CULTURE; COATINGS; GENE EXPRESSION; MINERALOGY; PEPTIDES; PHOSPHATASES; THREE DIMENSIONAL; TISSUE;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; ARGININE; ARGINYLGLYCYLASPARTIC ACID; ASPARAGINE; CALCIUM; GLYCINE; MOLECULAR SCAFFOLD; PHOSPHATE; POLYLYSINE; SCLEROPROTEIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE TISSUE; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAW; MARKER GENE; MATERIAL COATING; MINERALIZATION; MOLECULAR RECOGNITION; PERIOSTEUM;

BIOLOGICAL MARKERS; CALCIFICATION, PHYSIOLOGIC; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMOBILIZED PROTEINS; INTEGRINS; JAW; LACTIC ACID; OLIGOPEPTIDES; OSTEOGENESIS; PERIOSTEUM; POLYLYSINE; POLYMERS; TISSUE SCAFFOLDS;

EID: 84862755395     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34062     Document Type: Article

References (37)

1. Dixon MJ, Marazita ML, Beaty TH, Murray JC,. Cleft lip and palate: Understanding genetic and environmental influences. Nat Rev Genet 2011; 12: 167-178.
2. Kantlehner M, Finsinger D, Meyer J, Schaffner P, Jonczyk A, Diefenbach B, Nies B, Kessler H,. Selective RGD-mediated adhesion of osteoblasts at surfaces of implants. Angew Chem Int Ed 1999; 38: 560-562.
3. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E,. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006; 8: 315-317.
4. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP,. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006; 54: 1209-1221.
5. De Bari C, Dell'Accio F, Luyten FP,. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 2001; 44: 85-95.
6. Alexander D, Schafer F, Olbrich M, Friedrich B, Buhring HJ, Hoffmann J, Reinert S,. MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity. Cell Physiol Biochem 2010; 26: 1073-1080.
7. Alexander D, Schafer F, Munz A, Friedrich B, Klein C, Hoffmann J, Buhring HJ, Reinert S,. LNGFR induction during osteogenesis of human jaw periosteum-derived cells. Cell Physiol Biochem 2009; 24: 283-290.
8. Ringe J, Leinhase I, Stich S, Loch A, Neumann K, Haisch A, Haupl T, Manz R, Kaps C, Sittinger M,. Human mastoid periosteum-derived stem cells: Promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med 2008; 2: 136-146.
9. Agata H, Asahina I, Yamazaki Y, Uchida M, Shinohara Y, Honda MJ, Kagami H, Ueda M,. Effective bone engineering with periosteum-derived cells. J Dent Res 2007; 86: 79-83.
10. Hutmacher DW, Sittinger M,. Periosteal cells in bone tissue engineering. Tissue Eng 2003; 9 (Suppl 1): S45-S64.
11. Zhu SJ, Choi BH, Huh JY, Jung JH, Kim BY, Lee SH,. A comparative qualitative histological analysis of tissue-engineered bone using bone marrow mesenchymal stem cells, alveolar bone cells, and periosteal cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 164-169.
12. Chen DY, Shen H, Shao JJ, Jiang Y, Lu JX, He YH, Huang CL,. Superior mineralization and neovascularization capacity of adult human metaphyseal periosteum-derived cells for skeletal tissue engineering applications. Int J Mol Med 2011; 27: 707-713.
13. Habibovic P, de Groot K,. Osteoinductive biomaterialsa - Properties and relevance in bone repair. J Tissue Eng Regen Med 2007; 1: 25-32.
14. Bosman FT, Stamenkovic I,. Functional structure and composition of the extracellular matrix. J Pathol 2003; 200: 423-428.
15. Ruoslahti E, Pierschbacher MD,. New perspectives in cell-adhesiona - Rgd and Integrins. Science 1987; 238: 491-497.
16. Hersel U, Dahmen C, Kessler H,. RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003; 24: 4385-4415.
17. van der Flier A, Sonnenberg A,. Function and interactions of integrins. Cell Tissue Res 2001; 305: 285-298.
18. Barczyk M, Carracedo S, Gullberg D,. Integrins. Cell Tissue Res 2010; 339: 269-280.
19. Alexander D, Hoffmann J, Munz A, Friedrich B, Geis-Gerstorfer J, Reinert S,. Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells. J Mater Sci Mater Med 2008; 19: 965-974.
20. Thumshirn G, Hersel U, Goodman SL, Kessler H,. Multimeric cyclic RGD peptides as potential tools for tumor targeting: Solid-phase peptide synthesis and chemoselective oxime ligation. Chem Eur J 2003; 9: 2717-2725.
21. Westlin WF,. Integrins as targets of angiogenesis inhibition. Cancer J 2001; 7: S139-S143.
22. Pike DB, Ghandehari H,. HPMA copolymer-cyclic RGD conjugates for tumor targeting. Adv Drug Deliv Rev 2010; 62: 167-183.
23. Pierschbacher MD, Ruoslahti E,. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984; 309: 30-33.
24. Yang XB, Roach HI, Clarke NM, Howdle SM, Quirk R, Shakesheff KM, Oreffo RO,. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001; 29: 523-531.
25. Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, Nies B, Holzemann G, Goodman SL, Kessler H,. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 2000; 1: 107-114.
26. Hern DL, Hubbell JA,. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998; 39: 266-276.
27. Massia SP, Hubbell JA,. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol 1991; 114: 1089-1100.
28. Alvarez-Barreto JF, Shreve MC, Deangelis PL, Sikavitsas VI,. Preparation of a functionally flexible, three-dimensional, biomimetic poly(L -lactic acid) scaffold with improved cell adhesion. Tissue Eng 2007; 13: 1205-1217.
29. Kolhar P, Kotamraju VR, Hikita ST, Clegg DO, Ruoslahti E,. Synthetic surfaces for human embryonic stem cell culture. J Biotechnol 2010; 146: 143-146.
30. Lieb E, Hacker M, Tessmar J, Kunz-Schughart LA, Fiedler J, Dahmen C, Hersel U, Kessler H, Schulz MB, Gopferich A,. Mediating specific cell adhesion to low-adhesive diblock copolymers by instant modification with cyclic RGD peptides. Biomaterials 2005; 26: 2333-2341.
31. Schaffner P, Dard MM,. Structure and function of RGD peptides involved in bone biology. Cell Mol Life Sci 2003; 60: 119-132.
32. Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG,. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 2000; 113 (Part 10): 1677-1686.
33. Irvine DJ, Hue KA, Mayes AM, Griffith LG,. Simulations of cell-surface integrin binding to nanoscale-clustered adhesion ligands. Biophys J 2002; 82 (1, Part 1): 120-132.
34. Orimo H,. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch 2010; 77: 4-12.
35. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008; 13: 2001-2021.
36. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP,. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 2002; 17: 1570-1578.
37. Hamidouche Z, Fromigue O, Ringe J, Haupl T, Marie PJ,. Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signaling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation. BMC Cell Biol 2010; 11: 44.